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Vesicular aptasensor for the detection of
thrombin†
Andreas Mu¨ller and Burkhard Ko¨nig*
Self-assembled phospholipid vesicles are functionalized with thrombin-
binding aptamers using a thiol-click reaction. The resulting aptasensors
signal the binding of the analyte to the vesicle surface by changes of the
emission properties of membrane co-embedded reporter dyes.
The last two decades have seen considerable progress in the design
of biopolymer-based receptors for high-aﬃnity and -specificity
analyte binding. The first reports on the evolutionary selection of
RNA molecules binding to specific ligands in 19901 laid the
foundation for the development of numerousness nucleic acid
aptamers. A broad variety of ligands were targeted ranging from
small organic molecules2a to proteins2b and pathogens,2c and the
technique was applied in environmental and food analytics.3 With
an increasing number of available aptamers, suitable methods for
transforming the microscopic binding event into a macroscopic
signal were established.4 Fluorescence-based5a and electrochemical5b
detection methods are among the most important ones due to their
high sensitivities. They both typically rely on covalentmodification of
the aptamers with a luminescent or an electroactive moiety. Another
commonly used technique is based on hybridization of the aptamers
with antisense oligonucleotides whose displacement by the target
analytes induces a fluorescent or electrical response.6 The require-
ment of covalent reporter attachment at the aptamer or the need of
accordingly labeled complementary oligonucleotide strands can
make such assays laborious and costly. For that reason, label-free
strategies were investigated, but their general applicability is often
limited as they rely on specific structural characteristics of the
applied aptamers such as certain folding modes upon binding to
the target. Formation of a double helix domain, for example, allows
the intercalation of a suitable dye accompanied by a change of its
emission properties.7 Previously, our group reported on the modular
construction of luminescent chemosensors by means of unilamellar
vesicular membranes as self-assembled supporting frames for metal
complex receptors and fluorescent reporter sites.8 This strategy
facilitates an eﬀortless sensor preparation based on self-assembly
by simple mixing of diﬀerent functional amphiphiles in aqueous
solution. As a consequence, our method allows an easy variation of
the sensor composition, i.e., of the binding and signaling units, their
ratios and concentration on the surface and the physical properties
of the supporting vesicle membranes determined by the nature of
the phospholipids.9 We now expand the pool of available binding
sites to more complex structures based on molecules of biological
origin. As a model system, we immobilized the very well established
thrombin-binding 15-mer DNA aptamer10 on fluorescent phos-
pholipid vesicle surfaces. DNA-decorated liposomes have been
used as signal amplification tags,11 for controlled liposome
adhesion or fusion12 and for specific cell targeting with regard
to drug delivery.13 Moreover, the conjugated polymeric backbone
of oligonucleotide-functionalized polydiacetylene vesicles was
utilized as colorimetric sensing matrix for target detection.14
These reports prompted us to combine the concept of liposome-
anchored aptamers with our strategy of non-covalent receptor
and fluorophore co-embedding into phospholipid membranes.
As attachment site for thiol-modified aptamers, we incorporated
the amphiphilicmaleimideMal-C16 (Fig. 1, 5mol%) intomembranes
of small unilamellar DSPC vesicles. Amphiphilic pyrene Pyr-C18
(- vesicles V-Pyr) or rhodamine Rho-C18
15 (- vesicles V-Rho)
were co-embedded as reporter dyes (1–5 mol%). The synthesis of
Mal-C16 is described in the ESI,† preparation of Pyr-C18 was
performed by in situ click reaction of commercially available
N-(1-pyrenyl)maleimide and 1-octadecanethiol. The vesicle prepara-
tion was performed in 25mMHEPES buffer at pH = 7.4 according to
previously reported procedures (see ESI† for details).
Next, we functionalized the vesicle membrane covalently
with the aptamer by nucleophilic thiol–maleimide addition.
After addition of thiolated Apt-Thr (0.4–0.5 equivalents with
respect to the total amount of Mal-C16) to V-Pyr, we observed a
time-dependent decrease of the fluorescence signal indicating
the reaction progress on the vesicle surface. Phase separation
processes in the membrane result in high local concentrations
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of the embedded functional amphiphiles as it is evidenced by the
presence of the pyrene excimer signal of V-Pyr at 470 nm (Fig. 2A,
inset). We assume that the surface-anchored oligonucleotides
strongly impact the physical properties at the membrane inter-
face by their high negative charge and steric demand. This local
interference results in a partial fluorescence emission quenching
of the nearby pyrene aggregates (Fig. 3, top). Moreover, it is well
documented that nucleotides are able to quench the fluores-
cence of fluorophores, such as pyrene16 or rhodamine17 deriva-
tives, by photoinduced electron transfer. We believe that this
mechanism also contributes to the observed effect in our case.
Rhodamine-modified liposomes V-Rho exhibit a similar behavior
during functionalization with the aptamer Apt-Thr (Fig. 2B).
The thrombin-binding aptamer folds into a highly compact
G-quadruplex structure upon binding to thrombin.18 This chair-like
conformation is stabilized by a metal cation, particularly potassium
cations. Analogously to the sensing mechanism for the membrane
functionalization process, we believe that binding of the target to the
surface-bound oligonucleotide, accompanied by its conformational
change, has a drastic impact on the membrane structure which
triggers then the dynamic emission response of the fluorophore
molecules in close proximity (Fig. 3, bottom). At last, rather the
presence of the ‘‘aptamer bound’’ analyte at the membrane–water
interface causes the change of the emission signal than a defined
conformation of the immobilized oligonucleotide molecules.
High concentrations of potassium cations are known to induce
the transition of the oligonucleotide from random coil to the folded
form with a reported binding constant of lgKE 2.1.19 Therefore, we
first tested the suitability of the thrombin aptamer-functionalized
vesicles V-Pyr-Thr for K+ detection. The fluorescence titration
revealed an excimer signal change of almost 60% (Fig. 4, red
squares). Due to the relatively low binding aﬃnity of the aptamer
Fig. 1 Structures of the functional amphiphiles used for vesicle preparation
and of the immobilized aptamers.
Fig. 2 Fluorescence response monitoring the reaction progress of pyrene-
(A) and rhodamine-modified (B) vesicles during surface functionalization
with aptamer Apt-Thr.
Fig. 3 Principle of vesicle surface functionalization (I) and fluorescence
response after analyte binding (II).
Fig. 4 Fluorescence emission titrations of KCl versus aptamer-functionalized
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to potassium cations, KCl concentrations of up to 140 mM were
required to obtain a reasonable binding isotherm. In the same
concentration range, non-functionalized vesicles showed a smaller
non-specific response with linear relationship (Fig. 4, blue dots). We
explain this eﬀect by the huge change of ionic strength in the
aqueous buﬀer. It is well documented that high salt concentrations
have a strong influence on the membrane’s physical properties such
as surface polarity and hydration and thus can alter the emission of
membrane-embedded fluorophores.20 Non-linear curve fitting of the
obtained binding isotherm resulted in a logarithmic binding con-
stant of 1.3 (Table 1). The lower value of the potassium cation
binding constant compared to the reported one can be attributed to
the interference of specific binding and non-specific salt eﬀects.
Next, we investigated the detection of thrombin. Pyrene-
functionalized vesicles V-Pyr-Thr showed a relatively small
fluorescence increase upon addition of thrombin (E 20% at a
2.0 mM concentration of thrombin, see Fig. S4, ESI†), whereas
rhodamine-modified liposomes V-Rho-Thr exhibited a considerable
luminescence response (Fig. 5, red squares). As expected, non-
functionalized vesicles V-Rho did not significantly alter their
emission properties upon the addition of thrombin (Fig. 5,
blue dots).
Table 1 summarizes the apparent binding constants of the
vesicular aptasensors to diﬀerent analytes. All calculations were
performed by non-linear curve fitting using the equation for
1 : 1 binding.21 The aﬃnity constants of V-Rho-Thr to both bovine
and human thrombin are in good agreement with reported
literature values. The limit of detection was determined to be
25 nM (on basis of a signal to noise ratio of 3), while the sensors
span a dynamic range of up to 2 mM concentration of thrombin
(see ESI† for fluorescence titration data). The analytic results
are reproducible as shown by repeated measurements. Since
thrombin is a crucial enzyme in the blood coagulation cascade, its
concentration in circulating blood is low and often undetectable.
During clotting initiation, it becomes significantly elevated at a low
nanomolar concentration level and peaks at concentrations in
the low micromolar region during the propagation phase.11b,22
Thus, the dynamic recognition range of our sensor matches the
physiological concentration range.
To demonstrate that the interaction of thrombin with the
covalently membrane-attached aptamer is responsible for the
change of the rhodamine emission intensity, we prepared fluores-
cent vesicles lacking the amphiphilic binding anchor Mal-C16 and
incubated them with the thiolated thrombin-binding aptamer
Apt-Thr leading to no significant response upon analyte addition
(Fig. 5, orange diamonds).
We tested the specificity of our aptasensors by immobilizing
a non-binding control oligonucleotide Apt-Ctrl (Fig. 1) with
comparable length on the vesicle surface. The slight response
after thrombin addition can be attributed to non-specific
binding (Fig. 5, magenta triangles). Although thrombin has a
small negative overall charge in the used buﬀer system (pH: 7.4,
isoelectric point of thrombin: 7.0525), its numerous negatively
and positively charged residues are not distributed uniformly
over the whole molecule.26 They are clustered in a sandwich-like
structure of two highly positive poles, whose electrostatic fields
spread far into the extramolecular space. We suppose that the
electropositive exosites are capable to displace counterions from
the negatively charged oligonucleotide backbone by electrostatic
attractions.27
Emission titration using the protein elastase, which is besides
thrombin a member of the serine proteases enzyme family, versus
V-Rho-Thr indicates the aptamer–protein non-specific interaction.
The fluorescence intensity decreases during titration (Fig. 6), which
is in contrast to the emission intensity increase observed with
thrombin. Elastase has an isoelectric point of 9.5,28 and it is
assumed that its high positive net charge possibly results in
strong non-specific oligonucleotide–protein interactions,27 leading
to different fluorescence emission intensity changes.
In conclusion, we have developed a novel type of aptasensor
based on self-assembled, luminescent vesicle membranes, which
Table 1 Binding aﬃnities of fluorescent, aptamer-functionalized vesicles
to diﬀerent analytes
Vesicles Analyte lgK Reference
V-Pyr-Thr KCl 1.3 (8%) 2.119
V-Pyr-Thr Bovine thrombin 6.3 (3%) 7.123
V-Rho-Thr Bovine thrombin 7.2 (8%) 7.123
V-Rho-Thr Human thrombin 7.7a 6.7–7.624
a Single experiment.
Fig. 5 Binding isotherm of thrombin to aptamer-functionalized vesicles
V-Rho-Thr (red squares) and fluorescence response of control experiments:
non-functionalized vesiclesV-Rho (blue dots), maleimide-lackingV-Rho vesicles
incubated with Apt-Thr (orange diamonds) and vesicles V-Rho-Ctrl functiona-
lized with non-binding oligonucleotide Apt-Ctrl (magenta triangles).
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are functionalized with the thrombin-binding aptamer by nucleo-
philic thiol–maleimide addition. The high-affinity binding of the
aptamer to thrombin is indicated by a dynamic response of the
co-embedded fluorescent reporter molecules in the physiological
concentration range. The obtained binding constants are in
good agreement with the reported values. Despite of the observed
non-specific interactions in case of mismatched aptamer–protein
combinations, the specific binding to thrombin can be clearly
distinguished in the fluorescence output. As the reporter group is
neither covalently attached nor coordinated to the aptamer, an
inexpensive and easy variation of aptamer–fluorophor combina-
tions is possible. The signaling mechanism is independent of
specific conformational changes of the receptor molecules, which
may allow a broader application compared to previously reported
label-free aptasensors. An extension to other aptamers, enzymes or
proteins and the immobilization of the vesicular aptasensors on
solid supports can be readily envisaged.
A.M. thanks the Bayerische Elitefo¨rderung for a research
scholarship.
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